Textural analysis techniques in conjunction with low-frequency ultrasonic spectroscopy have been proposed for characterization of heterogeneous responses developed within tumours undergoing chemotherapy. Such characterization can be beneficial for early appraisal of tumour responses to the cancer therapy. Breast xenograft tumour-bearing animals were treated with chemotherapy. Animals were assessed with low-frequency ultrasound data acquired at different times after chemotherapy exposure. Following imaging, tumours underwent standard histological analysis for detecting cell-death effects. Several average and texture-based parameters were derived from normalized ultrasonic spectral parametric maps. Statistically significant differences were revealed between parameters extracted from treated and untreated tumours 12-24 hours after exposure. Regression analyses were also performed in order to assess levels of correlation between non-invasive ultrasonic surrogates of therapy response and standard histological findings, where strong correlations were obtained with a maximum r2 value of 0.98. Obtained results demonstrate that ultrasound-based textural properties of tissue can be used for characterizing the micro-structure alterations and heterogeneous responses within tumours early on during treatment. This is an important observation which can be applied clinically for treatment response monitoring and predicting patient responses to therapy early after therapy initiation.
INTRODUCTION
The potential of high-frequency (20-60 MHz) quantitative ultrasound for detecting cell death as a result of cancer therapy has been demonstrated previously (Banihashemi et al., 2008; Vlad et al., 2009 ). However, a limited depth of penetration (1-2 cm) is a limitation for the clinical application of high-frequency ultrasound constraining its applicability to superficial tissue sites. ultrasound that is conventionally used in the clinic has the advantage of deeper tissue penetration but provides a lower resolution. This advantage of lowfrequency ultrasound can potentially enable the non-invasive monitoring of responses of patients undergoing therapies for a wide variety of cancers.
The potential of low-frequency quantitative ultrasound to evaluate non-invasively the effects of cancer therapies has been investigated in this study in an in vivo pre-clinical mouse model. Evaluations of tumour responses to cancer treatment were carried out in a study using ultrasound data obtained at different times after chemotherapy exposure, in order to demonstrate the feasibility of using low-frequency quantitative ultrasound in conjunction with novel texture analysis techniques to detect and monitor cell death response. Results indicate coincident changes in the extracted spectral and textural quantitative parameters with the presence of histological cell death, and demonstrate the capacity of low-frequency quantitative ultrasound techniques in the appraisal of apoptotic tumour cell death resulting from cancer therapy administration. This work represents a fundamental forward step towards the adaptation of such methods to monitor non-invasively cancer treatments in patients where the low-frequency ultrasound is required with a deeper tissue penetration for tumour visualization.
MATERIALS AND METHODS
Human breast cancer (MDA-MB-231) tumors were xenografted in the hind leg of severe combined immunodeficiency disease (SCID) mice. Anaesthetized animals were treated with chemotherapy (doxirubicin and paclitraxel at 50 and 150 mg/m 2 , respectively) through intravenous tail injection. Experimentation used 20 animals equally divided into five groups of four. Each of the groups assessed at a different time after chemotherapy exposure, i.e. 0, 4, 12, 24, and 48 hours, respectively. Each mouse was imaged twice, i.e. pre-and post-treatment. Ultrasound radiofrequency (RF) data were collected using a conventional low-frequency system (Sonix RP, Ultrasonix, Vancouver, Canada) utilized a L14-5/38 transducer which pulsed at 10 MHz with a centre frequency of ~7 MHz. The system was used to collect three dimensional data with scan plane separations of ~0.5 mm. Following post-treatment imaging the tumours were excised for histopathological examination.
Ultrasound RF data analysis was performed using the normalized power spectrum (Banihashemi et al., 2008; Czarnota et al., 1997 Czarnota et al., , 1999 Feleppa et al., 1996; Kolios et al., 2001; Lizzi et al., 1983 Lizzi et al., , 1987 Lizzi et al., , 1997 Oelze et al., 2004; Vlad et al., 2009; Yang et al., 2007) and texture analysis on the spectral parametric maps (Haralick et al., 1973; Liao et al., 2011) . Ultrasound data was analyzed across several equally spaced scan planes. Standardized region of interest (ROI) were used which were located at the tumour centre. Statistical tests of significance (each treated group vs. the control group) based on changes in the determined spectral and textural parameters were carried out using t-test (unpaired, two-sided, α=0.05) .
Histological analysis was performed on tumour sections stained with haematoxylin and eosin (H&E) in addition to ISEL (in situ end nick labeling) immunohistochemistry for cell death. Cell death areas were quantified in histological tumour sections using Image-J (NIH, Maryland, USA).
RESULTS AND DISCUSSION
Low-frequency ultrasound data demonstrated alterations in quantitative spectral and textural parameters as noninvasive ultrasonic surrogates that could be linked to the presence of histological cell death. Figure 1 presents results of histological analysis performed to measure cell death areas in tumour sections obtained for different times after chemotherapy treatment. Generally, longer times after treatment resulted in larger areas of histological cell death within tumours.
Results obtained for average changes in the quantitative ultrasound spectral and textural parameters are summarized in Figure 2 . The results indicate considerable changes in the spectral parameters and the textural properties of spectral parametric maps for chemotherapy treated tumours, compared to untreated control tumours. Results of statistical tests of significance demonstrated significant differences between spectral and textural parameters extracted from treated and untreated tumours 12-24 hours after exposure. Regression analyses were also performed in order to assess levels of correlation between determined quantitative ultrasound parameters and standard histological findings. The analysis resulted in r 2 values ranging from 0.60 to 0.94 for single parameters. The linear combination of all the spectral parameters and the linear combination of all the textural parameters resulted in correlations with r 2 values of 0.68 and 0.98, respectively. Higher levels of correlation between ultrasonic textural parameters and the histological cell death measurements are likely due to the fact that tumour responses are frequently heterogeneous. Thus an analysis that takes those features into account, e.g. a textural analysis technique, is in particular advantageous.
In conclusion, this study indicates that ultrasound-based spectral and textural properties of tissue can be used for characterizing the micro-structure alterations in response to cancer therapies within tumours early on during treatment. This is an important observation which can be applied clinically for treatment response monitoring and predicting patient responses to therapy early after therapy initiation.
